RNAi for Therapeutic Market with Current Trends Analysis, 2017 – 2022
ReportsWeb.com has announced the addition of the “Global RNAi for Therapeutic Market Size Status and Forecast 2022” The report classifies the global RNAi for Therapeutic Market in a precise manner to offer detailed insights about the aspects responsible f
(EMAILWIRE.COM, November 16, 2017 ) This report studies the global RNAi for Therapeutic market, analyzes and researches the RNAi for Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead Research
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Get Sample Copy of this report at http://www.reportsweb.com/inquiry&RW00011218365/sample
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, RNAi for Therapeutic can be split into
siRNA
miRNA
shRNA
Market segment by Application, RNAi for Therapeutic can be split into
Cancer
Cardiovascular
HBV
Other
Browse complete Report at http://www.reportsweb.com/global-rnai-for-therapeutic-market-size-status-and-forecast-2022
Table of Content
1 Industry Overview of RNAi for Therapeutic
2 Global RNAi for Therapeutic Competition Analysis by Players
3 Company (Top Players) Profiles
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arbutus Biopharma (Tekmira)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Arrowhead Research
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.4.5 Recent Developments
4 Global RNAi for Therapeutic Market Size by Type and Application (2012-2017)
5 United States RNAi for Therapeutic Development Status and Outlook
6 EU RNAi for Therapeutic Development Status and Outlook
7 Japan RNAi for Therapeutic Development Status and Outlook
8 China RNAi for Therapeutic Development Status and Outlook
9 India RNAi for Therapeutic Development Status and Outlook
10 Southeast Asia RNAi for Therapeutic Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2017-2022)
12 RNAi for Therapeutic Market Dynamics
13 Market Effect Factors Analysis
Purchase complete report at http://www.reportsweb.com/buy&RW00011218365/buy/3300
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead Research
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Get Sample Copy of this report at http://www.reportsweb.com/inquiry&RW00011218365/sample
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, RNAi for Therapeutic can be split into
siRNA
miRNA
shRNA
Market segment by Application, RNAi for Therapeutic can be split into
Cancer
Cardiovascular
HBV
Other
Browse complete Report at http://www.reportsweb.com/global-rnai-for-therapeutic-market-size-status-and-forecast-2022
Table of Content
1 Industry Overview of RNAi for Therapeutic
2 Global RNAi for Therapeutic Competition Analysis by Players
3 Company (Top Players) Profiles
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arbutus Biopharma (Tekmira)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Arrowhead Research
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.4.5 Recent Developments
4 Global RNAi for Therapeutic Market Size by Type and Application (2012-2017)
5 United States RNAi for Therapeutic Development Status and Outlook
6 EU RNAi for Therapeutic Development Status and Outlook
7 Japan RNAi for Therapeutic Development Status and Outlook
8 China RNAi for Therapeutic Development Status and Outlook
9 India RNAi for Therapeutic Development Status and Outlook
10 Southeast Asia RNAi for Therapeutic Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2017-2022)
12 RNAi for Therapeutic Market Dynamics
13 Market Effect Factors Analysis
Purchase complete report at http://www.reportsweb.com/buy&RW00011218365/buy/3300
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results